Healthtech · Digital Care · 200–1000 · North America #b025_11

Our agents guide employees on benefits and file claims, so a wrong answer has real consequences. Every model change needs a repeatable check that accuracy held. We need evaluation sets we own and control, step-level tracing of what the agent did, and clear regression reports before release. Must pass a security review and never train on our customer data.

We ship many credit products in parallel, and our regression coverage cannot keep pace. Releases slow down or carry risk. A good solution must plug into our existing pipeline, cover lending flows like applications, servicing and payments, let QA teams across regions author tests without heavy engineering help, and pass a security review.

We ship AI replies that pull from each customer's own knowledge base, and right now our engineers judge draft quality by hand. It doesn't scale. We need a lightweight way to score retrieval and answer quality on the customer's own content before replies reach end users. No dedicated ML staff to run it, and pricing must be predictable.

We extract data from receipts and invoices across many languages and layouts, and accuracy on the long tail keeps slipping: odd formats, handwriting, mixed scripts, poor phone photos. We tune internally, but it eats time. A good solution must adapt to new formats quickly, show confidence per field, and run with enterprise-grade access controls.

We test our controls by hand: sample reviews, walkthroughs, office documents, once a year. By the time evidence is gathered, it is already stale. We want evidence collected continuously, mapped to the several regulatory frameworks we answer to, and pulled from our ticketing and cloud tooling. It must not need a dedicated admin or a generic checklist.

We wish a tool existed that pulls post-market surveillance data from our product and complaint systems and drafts the periodic report for clinician review, rather than clinicians compiling it by hand. We would judge it by hours saved per cycle, audit traceability of every statement, European data hosting, and references from regulated software vendors.

We run several certifications across multiple legal entities, and every year the same control testing and evidence gathering gets repeated per entity. A good solution must map one control set across entities, reuse evidence across frameworks, keep scopes separate, support local data residency, and plug into our identity provider and ticketing.

We wish we had one tool that maps every consent record and telehealth visit recording to the data rules of each participant's country, then enforces retention, access and transfer limits automatically. We would judge it by audit-ready evidence, validated configuration, proven use with patient-facing apps, and support across time zones. Fewer manual legal reviews per trial would be the clearest proof.

Before every model change reaches partners, we must prove our symptom assessment still performs against clinical cases. Today we lean on synthetic cases and automated metrics, which feels thin. A good solution gives versioned, reproducible evaluation sets, clinician-reviewed scoring, regression comparison between model versions, and fits our release pipeline and quality agreements.

We wish for a shared container platform built for mature application servers, not greenfield microservices. It should let many teams adopt it gradually while customer-hosted installs keep running. We would judge it on support for older server stacks, regional data residency, public sector references, and how little each team must rewrite to ship.

Every new customer means our analysts read long plan documents and re-key benefit details into structured data by hand. It slows onboarding and invites mistakes. A good solution must pull values from insurance plan summaries, flag low-confidence fields for human review, and validate against known plan rules. Plain OCR does not help us.

We are standing up first-line compliance controls and still lean on periodic manual checks and small sampled reviews. Problems surface weeks late. We want continuous monitoring that flags drift as it happens, with a clear audit trail for every decision, regional data hosting, and light setup that needs almost no engineering help from us.

We wish suppliers would publish a plain, verifiable map of where every byte of our data lives, including backups, logs and support access, with named sub-processors. We would judge it by independent audit evidence, contractual residency guarantees, and a clear exit path. Affordable tiers matter for a mid-sized team trialling it.

We wish for an evaluation workbench that reruns every model version against our full set of clinical findings and gives identical results each time, with locked data, code and settings. We would judge it by reproducibility across reruns, clear per-finding regression reports, audit trails fit for medical device reviewers, and how easily it plugs into our existing pipelines.

We ship investing features fast, and our backend engineers write and run tests themselves. As we grow, we worry a rushed release could break money movement. We need automated tests around transfers and account flows that plug into our existing pipeline, take little setup time, and fit a tiny budget. Heavy enterprise tooling is out.

We train and serve our own language models, and compute is one of our biggest cost lines. Today we struggle to see spend per workload, so trimming it is guesswork. A good solution must show cost per workload, run on premises or in sovereign clouds, work without permanent internet access, avoid large minimum commitments, and fit a small monthly budget.